Home
Richard Scott Struthers, President & CEO: Crinetics Pharmaceuticals CRNX Sell · Filed 24/05/10
Trade details
- Type
- Insider sale
- Amount
- $5,307,931.2
- Shares · price
- 107,448 sh · $49.40 a share
- Held after
- 257,485 sh
- Trade date
- 24/05/08
- Filed
- 24/05/10
- Days to filing
- 2 days
Sold 29.4% of holdings
- Share of holding sold
- 29.4%
Crinetics Pharmaceuticals trades, last 26 weeks
What else happened in Crinetics Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 24/04/08~24/06/07Richard Scott Struthers's recent trades
- Richard Scott Struthers
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 planCrinetics Pharmaceuticals
CRNX
$489.7K
13,196 sh
$489.7K
Filed 03/18
Traded 03/16
- Richard Scott Struthers
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 planCrinetics Pharmaceuticals
CRNX
$331.8K
8,785 sh
$331.8K
Filed 03/18
Traded 03/16
- Richard Scott Struthers
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 planCrinetics Pharmaceuticals
CRNX
$180K
4,000 sh
$180K
Filed 25/09/30
Traded 25/09/26
- Richard Scott Struthers
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 planCrinetics Pharmaceuticals
CRNX
$562.5K
16,463 sh
$562.5K
Filed 25/03/21
Traded 25/03/19
- Richard Scott Struthers
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 planCrinetics Pharmaceuticals
CRNX
$30.5K
875 sh
$30.5K
Filed 25/03/21
Traded 25/03/19